BARTOLINI, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 17.857
NA - Nord America 13.242
AS - Asia 5.400
SA - Sud America 708
AF - Africa 177
OC - Oceania 138
Continente sconosciuto - Info sul continente non disponibili 4
Totale 37.526
Nazione #
US - Stati Uniti d'America 13.114
PL - Polonia 11.362
RU - Federazione Russa 2.261
SG - Singapore 1.519
CN - Cina 1.285
IT - Italia 750
SE - Svezia 739
HK - Hong Kong 700
VN - Vietnam 680
IE - Irlanda 668
BR - Brasile 592
UA - Ucraina 507
KR - Corea 485
DE - Germania 449
FI - Finlandia 326
GB - Regno Unito 297
FR - Francia 273
IN - India 159
AU - Australia 135
ID - Indonesia 106
JP - Giappone 92
TR - Turchia 92
CA - Canada 71
NL - Olanda 64
JO - Giordania 50
BD - Bangladesh 47
AR - Argentina 44
CI - Costa d'Avorio 42
IQ - Iraq 35
SC - Seychelles 34
MX - Messico 33
PT - Portogallo 27
ZA - Sudafrica 23
CH - Svizzera 22
PK - Pakistan 22
ES - Italia 21
BE - Belgio 20
SA - Arabia Saudita 17
MA - Marocco 16
CO - Colombia 14
NG - Nigeria 14
AT - Austria 13
TH - Thailandia 13
AZ - Azerbaigian 12
EC - Ecuador 12
PE - Perù 12
EG - Egitto 11
LT - Lituania 11
NP - Nepal 11
PY - Paraguay 11
PH - Filippine 9
TN - Tunisia 9
UZ - Uzbekistan 9
VE - Venezuela 9
IL - Israele 8
BG - Bulgaria 7
CL - Cile 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
JM - Giamaica 7
KE - Kenya 7
RO - Romania 7
TW - Taiwan 7
AE - Emirati Arabi Uniti 5
AL - Albania 5
LB - Libano 5
OM - Oman 5
BH - Bahrain 4
BJ - Benin 4
ET - Etiopia 4
HR - Croazia 4
LV - Lettonia 4
PA - Panama 4
AM - Armenia 3
AO - Angola 3
BO - Bolivia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
IR - Iran 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
CR - Costa Rica 2
IS - Islanda 2
MD - Moldavia 2
MY - Malesia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BZ - Belize 1
EE - Estonia 1
EU - Europa 1
Totale 37.516
Città #
Warsaw 11.355
Santa Clara 1.941
Ashburn 1.564
Fairfield 1.092
Singapore 1.062
Jacksonville 745
Dublin 666
Chandler 607
Hong Kong 562
Woodbridge 506
Seattle 476
Cambridge 456
Wilmington 409
San Jose 408
Seoul 390
Houston 383
Council Bluffs 315
Beijing 284
Hefei 261
The Dalles 240
Dong Ket 223
Los Angeles 174
Altamura 170
Princeton 167
Ann Arbor 165
Buffalo 159
Boardman 153
Lawrence 137
Ho Chi Minh City 129
Lauterbourg 129
Helsinki 125
Boston 119
Dallas 113
Hanoi 110
Melbourne 109
Mumbai 104
Paris 97
Jakarta 94
San Diego 89
Phoenix 85
Milan 84
Tokyo 83
Medford 74
Moscow 73
Seongnam 73
Munich 70
Shanghai 68
New York 63
Izmir 62
Falls Church 55
São Paulo 47
Florence 44
Kent 43
Abidjan 42
Washington 40
Frankfurt am Main 33
Guangzhou 33
London 31
Turku 28
Hillsboro 27
Frankfurt Am Main 26
Norwalk 26
Auburn Hills 25
Chicago 24
Orem 24
West Jordan 24
Amsterdam 23
Verona 21
Bern 20
Brussels 20
Montreal 20
Redondo Beach 20
Groningen 19
Tianjin 19
Andover 18
Dearborn 18
Brooklyn 17
Baghdad 16
Guimarães 16
San Francisco 16
Atlanta 15
Philadelphia 15
Zhengzhou 15
Da Nang 14
Rome 14
Toronto 14
Yubileyny 14
Haiphong 13
North Bergen 13
Abuja 12
Baku 12
Johannesburg 12
Nuremberg 12
Rio de Janeiro 12
Belo Horizonte 11
Las Vegas 11
Amman 10
Chennai 10
Denver 10
Des Moines 10
Totale 28.107
Nome #
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer 634
M1 receptor activation is a requirement for arecoline analgesia. 610
Antinociceptive property of the nicotinic agonist AG4 in rodents 518
Acetyl-l-Carnitine in the Management of Pain During Methadone Withdrawal Syndrome. 429
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 411
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 409
The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats 403
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 401
AMITRIPTYLINE AND CLOMIPRAMINE ACTIVATE GI-PROTEIN SIGNALING PATHWAY IN THE INDUCTION OF ANALGESIA 389
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 388
Ryanodine receptors are involved in muscarinic antinociception in mice. 388
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 385
A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice 377
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 367
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 358
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 356
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. 355
5-HT1A AGONISTS INDUCE CENTRAL CHOLINERGIC ANTINOCICEPTION 355
A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. 336
Local anaesthetic activity of beta-caryophyllene. 335
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 333
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 333
PIRACETAM AND ANIRACETAM ANTAGONISM OF CENTRALLY ACTIVE DRUG-INDUCED ANTINOCICEPTION 332
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 330
ACETYL-L-CARNITINE INDUCES MUSCARINIC ANTINOCICEPTION IN MICE AND RATS 330
Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study. 326
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. 325
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. 323
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 318
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. 316
EFFECT OF POTASSIUM CHANNEL MODULATORS IN MOUSE FORCED SWIMMING TEST 314
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. 314
Role of intracellular calcium in acute thermal pain perception 314
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 313
NO DEVELOPMENT OF TOLERANCE TO ANALGESIA BY REPEATED ADMINISTRATION OF H1 ANTAGONISTS 311
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. 311
Effect of K+ channel modulation on mouse feeding behaviour 308
Pro-cognitive activity induced in the rat by low doses of R-(+)-hyoscyamine. 307
Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. 307
Baclofen antinociception is prevented by ICV injection of pertussis toxin and by an aODN to the mKv1.1 potassium channel.. 306
IMPROVEMENT OF COGNITIVE FUNCTIONS BY THE ACETYLCHOLINE RELEASER SM21 304
Prochlorperazine induces central antinociception mediated by the muscarinic system. 304
CENTRAL CHOLINERGIC CHALLENGING OF MIGRAINE BY TESTING SECOND-GENERATION ANTICHOLINESTERASE DRUG 303
Alpha-2 agonits induce amnesia through activation of the Gi-protein signalling pathway. 301
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents 301
Loss of muscarinic antinociception by antisense inhibition of M1 receptors. 299
PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL ACH RELEASER A-TROPANYL 2-(4-BROMOPHENYL)PROPIONATE (PG-9). 297
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 296
THE CENTRAL CHOLINERGIC SYSTEM HAS A ROLE IN THE ANTINOCICEPTION INDUCED IN RODENTS AND GUINEA-PIGS BY THE ANTIMIGRAINE DRUG SUMATRIPTAN 296
Memory facilitation with atropine: a paradoxical effect 294
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 293
Antinociceptive and antiamnesic properties of the presynaptic amplifier PG-9 293
ANTIAMNESIC ACTIVITY OF THE NICOTINIC AGONIST DBO-83 IN MICE 293
ROLE OF 5-HT1A RECEPTORS IN A MOUSE PASSIVE AVOIDANCE PARADIGM 292
KV1.1 CHANNEL ANTISENSE ATTENUATES LEARNING AND MODULATION OF DENTATE POLYSIALYLATED NCAM 292
EFFECT OF PERTUSSIS TOXIN ON BACLOFEN-AND DIPHENHYDRAMINE- INDUCED AMNESIA 292
Influence of potassium channel modulators on cognitive processes in mice 290
THE ROLE OF POTASSIUM CHANNELS IN ANTIHISTAMINE ANALGESIA 288
ROLE OF 5-HT4 RECEPTORS IN THE MOUSE PASSIVE AVOIDANCE TEST 287
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. 287
Role of Gi proteins in the antidepressant-like effect of amitriptyline and clomipramine. 286
Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like potassium channe 285
Caffeine induces central cholinergic analgesia. 284
ANTIAMNESIC EFFECT OF THE TWO NOVEL K-OPIOID AGONISTS, VA-100 AND VA-101, IN THE MOUSE PASSIVE AVOIDANCE TEST 284
Endogenous morphine modulates acute thermonociception in mice. 284
In vitro characterization of a novel, potent and selective M3 antagonist 283
ANTINOCICEPTIVE EFFECT OF R-(+)-HYOSCYAMMINE ON THE CONJUNCTIVAL REFLEX TEST IN RABBITS 282
Involvement of potassium channels in amitriptyline and clomipramine analgesia. 279
ANTIHISTAMINE ANTINOCICEPTION IS MEDIATED BY GI-PROTEIN ACTIVATION 278
Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes. 276
Neuropathy-induced apoptosis: Protective effect of physostigmine 276
H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. 270
Inactivation of Gi proteins induces an antidepressant-like effect in the mouse forced-swimming test. 270
ANTINOCICEPTION INDUCED BY SM32 DEPENDS ON CENTRAL CHOLINERGIC MECHANISM 268
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms 268
PHARMACOLOGICAL IDENTIFICATION OF SM-21, THE NOVEL SIGMA2 ANTAGONIST 266
Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat 265
Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception. 253
Memory facilitation and stimulation of endogenous nerve growth factor synthesis by the ACh releaser PG9 253
Antagonism by piracetam of baclofen antinociception 251
Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse. 248
Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors 241
Are the contractions of rabbit peripheral lung, guinea-pig gall-bladder and guinea-pig uterus mediated by identical receptor subtype? 239
ANTINOCICEPTION INDUCED BY AMITRIPTYLINE AND IMIPRAMINE IS MEDIATED BY A2A-ADRENOCEPTORS 237
Binding Profiles of a Series of 2-Arylpropionic Acid Esters on Cloned Human Muscarinic Receptors Subtypes (m1-m5) and Their Relationship to Nootropic Activity 236
Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against Gi-protein a subunits. 218
AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram). 208
1,4-Diazabicyclo[4.3.0]nonan-9-ones and 1,4-diamidopiperazines as new classes of highly potent nootropic drugs 206
Antidepressant-like effect of artemin in mice: a mechanism for acetyl-l-carnitine activity on depression 201
INVESTIGATION INTO THE ROLE OF HISTAMINE RECEPTORS IN RODENT ANTINOCICEPTION 199
S-(-)-ET126: a potent and selective M1 antagonist 198
ANALGESIC, ANTIMUSCARINIC ACTIVITY AND ENANTIOSELECTIVITY OF THE FOUR ISOMERS OF 3-QUINUCLIDINYL TROPATE AS COMPARED WITH THE ENANTIOMERS OF HYOSCYAMINE 194
Gi/o proteins: expression for direct activation enquiry 190
Synthesis and Enantioselectivity of the Enantiomers of PG9 and SM21, New Potent Analgesic and Cognition-Enhancing Drugs 189
ANTINOCICEPTION INDUCED BY SYSTEMIC ADMINISTRATION OF LOCAL ANAESTHETICS DEPENDS ON A CENTRAL CHOLINERGIC MECHANISM 184
1,4-Diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs 184
INVOLVEMENT OF CENTRAL CHOLINERGIC NEUROTRANSMISSION IN METOCLOPRAMIDE ANALGESIA 180
Acetyl-L-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy 179
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A SERIES OF ARYL TROPANYL ESTERS AND AMIDES CHEMICALLY RELATED TO 1H-INDOLE-3-CARBOXYLIC ACID ENDO 8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL ESTER 178
Chiral synthesis and pharmacological evaluation of the enantiomers of SM32, a new analgesic and cognition-enhancing agent. 176
Totale 30.023
Categoria #
all - tutte 83.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021389 0 0 0 0 0 0 0 0 0 0 0 389
2021/20221.296 29 155 106 36 65 74 55 75 77 86 247 291
2022/20232.779 261 464 135 206 241 505 383 158 257 13 102 54
2023/20241.453 57 132 219 72 81 228 48 449 29 49 45 44
2024/20256.621 241 684 416 892 1.815 824 134 368 299 273 430 245
2025/20267.527 834 1.098 673 422 852 442 1.012 468 584 668 429 45
Totale 37.671